Movatterモバイル変換

[0]ホーム
URL:

MXPA03001930A - Tnf receptor-like molecules and uses thereof. - Google Patents

Tnf receptor-like molecules and uses thereof.

Info

Publication number
MXPA03001930A
MXPA03001930AMXPA03001930AMXPA03001930AMXPA03001930AMX PA03001930 AMXPA03001930 AMX PA03001930AMX PA03001930 AMXPA03001930 AMX PA03001930AMX PA03001930 AMXPA03001930 AMX PA03001930AMX PA03001930 AMXPA03001930 AMX PA03001930A
Authority
MX
Mexico
Prior art keywords
polypeptides
molecules
tnf receptor
methods
amelioration
Prior art date
Application number
MXPA03001930A
Other languages
Spanish (es)
Inventor
Gang Yu
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen IncfiledCriticalAmgen Inc
Publication of MXPA03001930ApublicationCriticalpatent/MXPA03001930A/en

Links

Classifications

Landscapes

Abstract

Novel MK61 polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, selective binding agents, and methods for producing MK61 polypeptides. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with MK61 polypeptides.
MXPA03001930A2000-09-052001-09-05Tnf receptor-like molecules and uses thereof.MXPA03001930A (en)

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
US23019100P2000-09-052000-09-05
PCT/US2001/027631WO2002020762A2 (en)2000-09-052001-09-05Tnf receptor-like molecules and uses thereof

Publications (1)

Publication NumberPublication Date
MXPA03001930Atrue MXPA03001930A (en)2003-06-19

Family

ID=22864263

Family Applications (1)

Application NumberTitlePriority DateFiling Date
MXPA03001930AMXPA03001930A (en)2000-09-052001-09-05Tnf receptor-like molecules and uses thereof.

Country Status (10)

CountryLink
US (3)US7153669B2 (en)
EP (1)EP1317536B1 (en)
JP (1)JP2004508043A (en)
AT (1)ATE431405T1 (en)
AU (2)AU8881201A (en)
CA (1)CA2421588C (en)
DE (1)DE60138715D1 (en)
ES (1)ES2327102T3 (en)
MX (1)MXPA03001930A (en)
WO (1)WO2002020762A2 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20040248790A1 (en)*2001-09-032004-12-09Shuji HinumaNovel secretory proteins and dna thereof
EP1338609A1 (en)*2002-02-212003-08-27MEMOREC Stoffel GmbH-Medizinisch-Molekulare Entwicklung, KölnA further KDR receptor and the use thereof
JP2008515434A (en)*2004-10-082008-05-15ジョージア テック リサーチ コーポレイション Microencapsulation of cells in hydrogels using electrostatic potential
CN102482321B (en)2009-06-222015-06-17安姆根有限公司Refolding proteins using a chemically controlled redox state
US8940878B2 (en)*2009-06-252015-01-27Amgen Inc.Capture purification processes for proteins expressed in a non-mammalian system
JP2013512674A (en)2009-12-022013-04-18アクセルロン ファーマ， インコーポレイテッド Compositions and methods for increasing the serum half-life of an Fc fusion protein
WO2012075238A1 (en)2010-12-022012-06-07Genentech, Inc.Novel receptor-ligand interaction and uses thereof
EP2718328A4 (en)2011-06-082014-12-24Acceleron Pharma IncCompositions and methods for increasing serum half-life
UY35148A (en)2012-11-212014-05-30Amgen Inc HETERODIMERIC IMMUNOGLOBULINS
US9708375B2 (en)2013-03-152017-07-18Amgen Inc.Inhibitory polypeptides specific to WNT inhibitors
CA2923145A1 (en)2013-09-052015-03-12Amgen Inc.Fc-containing molecules exhibiting predictable, consistent, and reproducible glycoform profiles
US10156562B2 (en)2014-05-162018-12-18Amgen Inc.Assay for detecting Th1 and Th2 cell populations
US20200131518A1 (en)2017-03-142020-04-30Amgen Inc.Control of total afucosylated glycoforms of antibodies produced in cell culture
AU2019243848B2 (en)2018-03-262025-01-02Amgen Inc.Total afucosylated glycoforms of antibodies produced in cell culture
WO2021062372A1 (en)2019-09-262021-04-01Amgen Inc.Methods of producing antibody compositions
AU2020405230A1 (en)*2019-12-202022-06-23Amgen Inc.Mesothelin-targeted CD40 agonistic multispecific antibody constructs for the treatment of solid tumors
WO2021247892A1 (en)2020-06-042021-12-09Amgen Inc.Assessment of cleaning procedures of a biotherapeutic manufacturing process
KR20230087539A (en)2020-10-152023-06-16암젠 인크 Relative Unbound Glycans in Antibody Production Methods
CA3222409A1 (en)2021-06-072022-12-15Amgen Inc.Using fucosidase to control afucosylation level of glycosylated proteins
EP4413377A1 (en)2021-10-052024-08-14Amgen Inc.Fc-gamma receptor ii binding and glycan content
WO2023215725A1 (en)2022-05-022023-11-09Fred Hutchinson Cancer CenterCompositions and methods for cellular immunotherapy
AU2024256160A1 (en)2023-04-202025-10-02Amgen Inc.Methods of determining relative unpaired glycan content
CN116459344B (en)*2023-04-282025-03-18上海市生物医药技术研究院 Anti-inflammatory therapeutic application of a MNSFβ/RC3H1 PPI interfering peptide
WO2025038600A1 (en)2023-08-142025-02-20Amgen Inc.Methods for reducing yellow color
WO2025101820A1 (en)2023-11-082025-05-15Fred Hutchinson Cancer CenterCompositions and methods for cellular immunotherapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
ATE289350T1 (en)1989-04-212005-03-15Amgen Inc TNF RECEPTOR, TNF BINDING PROTEINS AND DNA CODING THEREOF
IL95031A (en)1989-07-182007-03-08Amgen IncMethod for the production of a human recombinant tumor necrosis factor inhibitor
US5194596A (en)*1989-07-271993-03-16California Biotechnology Inc.Production of vascular endothelial cell growth factor
US5350836A (en)*1989-10-121994-09-27Ohio UniversityGrowth hormone antagonists
DE4004317A1 (en)1990-02-131991-08-14Basf Ag NEW 3-SUBSTITUTED PYRIDINE METHANOLS AND FUNGICIDES CONTAINING THEM
US5521288A (en)*1990-03-261996-05-28Bristol-Myers Squibb CompanyCD28IG fusion protein
US5843789A (en)*1995-05-161998-12-01Neomecs IncorporatedMethod of analysis of genomic biopolymer and porous materials for genomic analyses
EP1064295A4 (en)*1998-03-162004-06-16Millennium Pharm Inc METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME-18p RELATED DISORDERS
US6660843B1 (en)*1998-10-232003-12-09Amgen Inc.Modified peptides as therapeutic agents
WO2001055350A1 (en)2000-01-312001-08-02Human Genome Sciences, Inc.Nucleic acids, proteins, and antibodies
US6783969B1 (en)*2001-03-052004-08-31Nuvelo, Inc.Cathepsin V-like polypeptides

Also Published As

Publication numberPublication date
AU8881201A (en)2002-03-22
EP1317536A2 (en)2003-06-11
WO2002020762A2 (en)2002-03-14
JP2004508043A (en)2004-03-18
CA2421588C (en)2010-01-26
ES2327102T3 (en)2009-10-26
WO2002020762A8 (en)2004-03-04
DE60138715D1 (en)2009-06-25
ATE431405T1 (en)2009-05-15
CA2421588A1 (en)2002-03-14
US20070015219A1 (en)2007-01-18
EP1317536B1 (en)2009-05-13
WO2002020762A3 (en)2002-08-08
US20090325880A1 (en)2009-12-31
US20020150977A1 (en)2002-10-17
AU2001288812B2 (en)2007-05-10
US7153669B2 (en)2006-12-26
US7569387B2 (en)2009-08-04

Similar Documents

PublicationPublication DateTitle
AU8881201A (en)Tnf receptor-like molecules and uses thereof
MXPA02012743A (en)Il-17 molecules and uses thereof.
MXPA03002413A (en)B7-like molecules and uses thereof.
WO2001092308A3 (en)Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
WO2002002624A3 (en)B7-like molecules and uses thereof
WO2001072957A3 (en)Fibroblast growth factor-like molecules and uses thereof
WO2001070977A3 (en)Fibroblast growth factor receptor-like molecules and uses thereof
MXPA02011656A (en)Nrg 2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods.
WO2001068859A3 (en)Il-17 receptor like molecules and uses thereof
WO2002000724A3 (en)Thymic stromal lymphopoietin receptor molecules and uses thereof
WO2001068705A3 (en)Il-17 receptor like molecules and uses thereof
WO2001068854A3 (en)Fibroblast growth factor-like molecules and uses thereof
MXPA03000979A (en)C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF.
WO2000053776A3 (en)Human kallikrein-like genes
WO2003024991A3 (en)Tall-1 receptor molecules and uses thereof
WO2001042474A3 (en)Interferon-like molecules and uses thereof
WO2002000723A3 (en)Thymic stromal lymphopoietin receptor molecules and uses thereof
PL374550A1 (en)Il-17 like molecules and uses thereof
WO2001074903A3 (en)Cd20/ige-receptor like molecules and uses thereof
WO2001059120A3 (en)Il-17 like molecules and uses thereof
MXPA03010728A (en)B7 related protein-2 molecules and uses thereof.
WO2002083736A3 (en)G-protein coupled receptor molecules and uses thereof
MXPA03000980A (en)C3b/c4b complement receptor-like molecules and uses thereof.
WO2002014489A3 (en)Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof
WO2002099108A3 (en)Atp-binding cassette transporter-like molecules and uses thereof

Legal Events

DateCodeTitleDescription
FGGrant or registration
[8]ページ先頭
©2009-2025 Movatter.jp